Through the identification of a novel stromal–tumor communication axis, we offer profound insights into the non-cell-autonomous regulation of ferroptosis and highlight COX4I2 as a potential prognostic biomarker and therapeutic target. The gene discussed is COX4I2; the disease is neoplasm.